Impact Factor
3.92
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.80
2,685 total citations
h5-index
47
h5 depth signal
Cited share
82.5%
612 of 742
Total citations
2,685
Citation footprint
Metric signal
3.36
External metric anchor
Self-citation
1.9%
51 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
2,039
China
443
United Kingdom
309
Canada
303
Netherlands
261
Citing Fields of Research
Breast Cancer
4,096
Genetics & Genomics
312
Palliative Care
228
Immunology
213
Cancer & Development
187
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
12,233
Articles tracked across the journal lifetime
Indexed publication set
742
612 cited publications
Last 12 months
257
21.4 publications/month
Open access share
47.5%
122 OA publications in the last year
Leading citing country
United States
2,039 citing publications
Leading citing field
Breast Cancer
4,096 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 1981-
v1n1, 1981-
Active Coverage
Research Focus & Classification
Indexed Subjects
Breast Cancer
Broad Categories
Neoplasms
Breast Cancer
MeSH Descriptors
Breast Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1007/s10549-026-08094-1
Open DOI
Artificial intelligence decision support for breast ultrasound: potential to reduce benign biopsies
02
DOI 10.1007/s10549-026-08097-y
Open DOI
Age-specific survival after breast conservation versus mastectomy for ductal carcinoma in situ of the breast
Purpose: Breast conservation for invasive breast cancer is associated with better survival and fewer complications than mastectomy, which is especially relevant for older patients. It is unclear whether this can be extrapolated to ductal...
03
04
DOI 10.1007/s10549-026-08102-4
Open DOI
A breast clinical scoring system to identify women with Idiopathic granulomatous Mastitis
05
06
07
DOI 10.1007/s10549-026-08108-y
Open DOI
Surgical management in HER2 + de novo metastatic breast cancer: disease progression and survival
08
DOI 10.1007/s10549-026-08106-0
Open DOI
National trends in dual de-escalation of axillary surgery and adjuvant radiation in early-stage HR+/HER2- breast cancer
Purpose: De-escalation has become standard across breast cancer management. Many early-stage HR+/HER2-negative breast cancers are eligible for both SLNB omission and accelerated partial breast irradiation (APBI). However, the oncologic s...
09
DOI 10.1007/s10549-026-08107-z
Open DOI
Diagnosis-to-surgery lead time and future-health worry in women with primary breast cancer: a longitudinal Swedish registry-based cohort study
Purpose: The interval between breast cancer diagnosis and surgery is psychologically demanding, and meeting the Swedish standardised care pathway target has remained challenging. We examined whether diagnosis-to-surgery lead time is asso...
10
Bibliographical & Catalog Notes
Also issued online.
Vol. 14, no. 1 (1989)19941027 Notice published Printed on acid-free paper